News Focus
News Focus
icon url

asmarterwookie

06/06/15 9:14 AM

#222559 RE: PPHMVERYLONG #222558

WHY WE ARE AT $1.50:


We're not and why are you here then?

sheesh

wook
icon url

cheynew

06/06/15 9:25 AM

#222561 RE: PPHMVERYLONG #222558

Please correct me if I am wrong, but I thought if a drug was already proved safe (what Phase 1 trials are for) a drug would skip to Phase 2. I believe the announced upcoming trials with nivolumab is a Phase 2 and breast cancer will be Phase 2/3.
icon url

Couch

06/06/15 9:37 AM

#222564 RE: PPHMVERYLONG #222558

Face it- Garnick, Sunrise & MSK - in that order make this a new ballgame.

AND no ongoing phase II trials huh?? Looks like that will be wiped off the negative list soon enough!

Phase II/III Combination Trial to Advance Bavituximab with Chemotherapy Combinations in HER2 Negative Breast Cancer

The company plans to initiate an open-label multi-center, randomized Phase II trial of the anti-PD-1 monoclonal antibody nivolumab (marketed as Opdivo®) versus nivolumab plus bavituximab in patients with previously treated locally advanced or metastatic NSCLC. Enrollment will include patients with squamous and non-squamous NSCLC who have not received a prior PD-L1 or PD-1 inhibitor. The primary endpoint of this trial will be overall response rate (ORR) with secondary endpoints including tumor response and duration, progression free survival, overall survival (OS) and safety. The trial is in the final stages of design and the details of which will be made available once details are completed. Trial initiation is anticipated in the second half of 2015.
icon url

bigbro1

06/06/15 10:04 AM

#222568 RE: PPHMVERYLONG #222558

With all said you are still here hoping for best ! Good luck :)
icon url

EndoTarget

06/06/15 10:45 AM

#222571 RE: PPHMVERYLONG #222558

You missed your coffee this morning????

Made 17 grands since early March on a 60K(long and trading) position.

It took me years to finally understand being verylong and passive is counterproductive.

Have your Quad you'll feel better.

Endo
icon url

realist1

06/06/15 11:32 AM

#222581 RE: PPHMVERYLONG #222558

Hey, maybe they can dust off Cotara?
Or put out another opportunistic PR, like when they did bird flu or ebola.
Or another NO MONEY partnership?

icon url

JJ1223

06/06/15 11:54 AM

#222587 RE: PPHMVERYLONG #222558

WHY WE ARE AT $1.50:



1) NO DRUG CURRENTLY APPROVED.


2) LOSES TEN OF MILLIONS EVERY YEAR.


3) NO LATE STAGE RESULTS TO BE RELEASED ANYTIME SOON.


4) ONLY ONE DRUG IN DEVELOPMENT AND THAT DRUG HAS NEVER HAD A SUCESSFULL BEYOND QUESTION LATE STAGE TRIAL(STAGE TWO OR GREATER).

5) NO PARTNER TO FUND PLANNED EXPANSION(YOU KNOW WHAT THAT MEANS) DILUTION HERE I COME.


QUESTION: WHAT HAS HAPPENDED IN 2015 THAT WOULD MAKE A PARTNER COME ABOARD NOW:



Wow, now your viewpoint has a negative slant on all aspects of PPHM. As a friendly suggestion, take a few minutes to write down all the positive things going on with the company right now. Forget the share price for now. List only items that you think may have a short term positive impact on the PPS. Look at the situation only from a positive perspective. If you can do that on paper, and do not come up with enough good reasons to own the stock, you might think about changing your name to PPHMLONGGONE. Enough reasons are there if you look. Invest in what you believe in, or it makes no sense to risk your money. IMHO